A groundbreaking study shatters the myth of permanent cardiac damage, revealing that the heart can naturally trigger cell ...

In research, induced pluripotent stem (iPS) cells are derived from skin, urine, or blood samples and developed into other cells, like heart tissue, that researchers want to study. Because of the ...

A protein-level tension sensor reveals how cell shape and sarcomere maturity determine where cardiomyocytes carry mechanical ...

Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year. Damage caused by these diseases is particularly difficult to repair, since ...

Atrial fibrillation (AF), the most common chronic cardiac arrhythmia in clinical practice, is very challenging to treat once ...

Dr. Fernanda Cristina Paccola Mesquita’s scientific journey has been driven by a profound curiosity about how the human heart develops, repairs itself, and ultimately fails in disease. Early in her ...

James Marchant is a postdoctoral researcher in Alexandre Colas’s group at Sanford Burnham Prebys. In this Postdoc Portrait, he shares his work on developing a gene therapy for heart failure, why his ...

New study reveals how influenza virus infiltrates heart tissue via specialised immune cells, triggering damaging interferon ...

Novo Nordisk A/S terminated its global licensing deal with Japan’s Heartseed Inc. for its allogeneic induced pluripotent stem cell (iPSC)-derived cardiomyocytes.

Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the ...